Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Authors not listed

Amoneta Diagnostics SAS · 2019

Abstract

This is a 24-month, monocentric, exploratory and observational clinical study aimed at developing and validating a blood-based diagnostic test for Alzheimer's disease (AD). The test is based on two complementary biomarkers: conformational changes in Protein Kinase C (PKC) and aggregation of β-amyloid peptide on red blood cell membranes. The study will also establish a biobank of serum, plasma, urine, and RNA samples for future biomarker research.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2019). Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease. <em>Amoneta Diagnostics SAS</em>. https://clinicaltrials.gov/study/NCT07294586
Vancouver
Anonymous. Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease. Amoneta Diagnostics SAS. 2019.
BibTeX
@misc{anon2019Explor, title = {Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease}, author = {Anonymous}, journal = {Amoneta Diagnostics SAS}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings